Navigation Links
Sangamo BioSciences Receives Michael J. Fox Foundation Funding to Develop Novel Drug for the Treatment of Parkinson's Disease
Date:7/1/2010

forward to collaborating with Sangamo to further develop this promising therapeutic approach."

Sangamo's technology platform permits the development of highly specific ZFP TFs that can be used to regulate genes at the DNA level. Using a ZFP TF, a gene can be activated in a patient's own cells in its natural cellular context. Use of a ZFP TF to activate the GDNF gene in the brain — as compared to addition of a GDNF cDNA or the recombinant protein —allows the delivery of a more physiologically relevant dose of the growth factor which may be a safer and more effective alternative. This is of particular significance when targeting potent natural growth factors such as GDNF, where sufficient but not super-physiological levels of the therapeutic protein are required to achieve efficacy.

"We are very pleased that The Michael J. Fox Foundation continues to support these IND-enabling studies as part of our program to develop a novel ZFP Therapeutic for PD," said Edward Lanphier, Sangamo's president and CEO. "ZFP TF-driven gene activation underpins our lead ZFP Therapeutic (SB-509) which has been evaluated in four Phase 2 clinical trials for diabetic peripheral neuropathy and demonstrated both clinical efficacy and an excellent safety profile. Preclinical success in PD models with the ZFP TF activator of GDNF will support the evaluation of this approach in the clinic.  Moreover, it would demonstrate the potential for ZFP TF use in the brain and set the stage for the further application of our powerful technology platform to other genes that may have a therapeutic benefit in PD."

About Parkinson's Disease

Parkinson's disease is a chronic, progressive disorder of the central nervous system and results from the loss of cells in a section of the brain called the substantia nigra. These cells produce
'/>"/>

SOURCE Sangamo BioSciences, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Sangamo BioSciences and Sigma-Aldrich Announce Nature Biotechnology Study Demonstrating Zinc Finger Technology for Modification of Human Stem Cells
2. Sangamo BioSciences Announces Completion of Enrollment of Phase 2 Clinical Trial of ZFP Therapeutic for Diabetic Neuropathy
3. Sangamo BioSciences Reports 2007 Fourth Quarter and Year-End Financial Results
4. Sangamo BioSciences and Sigma-Aldrich Announce Publication of Study Demonstrating Zinc Finger Technology for Rapid Generation of Knock-Out Cell Lines
5. Sangamo BioSciences Announces Presentation of Data on ZFP Therapeutic for Glioblastoma at American Association for Cancer Research (AACR) Meeting
6. Sangamo BioSciences Provides Update on Diabetic Neuropathy Clinical Programs
7. Sangamo BioSciences Announces Presentation of Phase 1b ZFP Therapeutic Data at American Diabetes Association Meeting
8. Sangamo BioSciences Announces Nature Biotechnology Study Demonstrating the Use of Zinc Finger Nucleases to Generate HIV Resistant T Cells
9. Sangamo BioSciences Initiates Phase 2 Clinical Trial of Treatment for Amyotrophic Lateral Sclerosis (ALS)
10. Sangamo BioSciences Provides Update on Companys 2008 Progress and 2009 Objectives
11. Sangamo BioSciences Announces Presentations at Two Upcoming Investor Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/17/2014)... Sept. 17, 2014   GS1 US ... implement GS1 Standards to support the 2013 Drug ... safety and security in the pharmaceutical supply chain. ... to U.S. Pharmaceutical Supply Chain Business Processes to ... was developed in collaboration with GS1 Healthcare ...
(Date:9/17/2014)... -- Sutro Biopharma, a biopharmaceutical company developing antibody drug ... Merck KGaA, Darmstadt, Germany , which ... States and Canada , ... antibody drug conjugates (ADCs). ADCs are composed of an ... thought to specifically target and deliver the cytotoxic drug ...
(Date:9/17/2014)... ARMONK, N.Y. , Sept. 17 2014 ... Caris Life Sciences is using IBM technical computing ... profiling services for cancer patients. These services deliver ... therapeutic plans for each patient,s unique cancer, which ... costs to the healthcare system in general. ...
Breaking Medicine Technology:New Healthcare Industry Guideline Delineates How to Implement GS1 Standards to Support Requirements of the 2013 Drug Supply Chain Security Act 2New Healthcare Industry Guideline Delineates How to Implement GS1 Standards to Support Requirements of the 2013 Drug Supply Chain Security Act 3New Healthcare Industry Guideline Delineates How to Implement GS1 Standards to Support Requirements of the 2013 Drug Supply Chain Security Act 4Sutro Biopharma and Merck KGaA of Darmstadt, Germany, to Partner on Development of Antibody Drug Conjugates 2Sutro Biopharma and Merck KGaA of Darmstadt, Germany, to Partner on Development of Antibody Drug Conjugates 3Sutro Biopharma and Merck KGaA of Darmstadt, Germany, to Partner on Development of Antibody Drug Conjugates 4Caris Life Sciences Selects IBM to Accelerate Use of Molecular Profiling in Cancer Treatment Selection 2Caris Life Sciences Selects IBM to Accelerate Use of Molecular Profiling in Cancer Treatment Selection 3Caris Life Sciences Selects IBM to Accelerate Use of Molecular Profiling in Cancer Treatment Selection 4
... MALVERN, Pa., May 17, 2012  Egalet Ltd., a privately ... and abuse-deterrent medications, announced today Bob Radie, president and ... Life Sciences Europe conference on May 23 organized ... the company,s patented technology and pipeline of abuse-deterrent opioids ...
... LOUIS, May 17, 2012 , "9 Trends" ... , Helping Members Make Healthier Decisions , ... , Developing New Ways to Comprehensively Manage Specialty Care ... Poor health choices add billions in cost to ...
Cached Medicine Technology:Egalet to Present at Life Sciences Europe Conference 2Poor Health Decisions Cost Billions; New Report Identifies Unhealthy Behavior as Top Concern of Benefit Providers 2Poor Health Decisions Cost Billions; New Report Identifies Unhealthy Behavior as Top Concern of Benefit Providers 3Poor Health Decisions Cost Billions; New Report Identifies Unhealthy Behavior as Top Concern of Benefit Providers 4Poor Health Decisions Cost Billions; New Report Identifies Unhealthy Behavior as Top Concern of Benefit Providers 5
(Date:9/17/2014)... Dennis Thompson HealthDay ... -- Diabetics and dieters who turn to artificial sweeteners ... themselves any favors, a new Israeli study suggests. ... despite containing no calories, researchers found in human and ... appear to alter the bacteria residing in the intestines ...
(Date:9/17/2014)... more than 87,000 men, a global team of scientists ... common differences in the genetic code -- that increase ... believed to be the largest of its kind, has ... array of ethnic groups comprising men of European, African, ... from smaller studies, according to William B. Isaacs, Ph.D., ...
(Date:9/17/2014)... Mercy “topped out” the world’s first ... beam into place. Sister of Mercy Claudia Ward also ... and video of the event, including footage from an ... http://bit.ly/MercyVirtual .) , “The topping out means we are ... thousands of patients regardless of the hour or location,” ...
(Date:9/17/2014)... Fremont, California (PRWEB) September 17, 2014 ... remote access connectivity solutions, today announced that it ... Appliance in October 2014. This new offering will ... 365 and other Software-as-a-Service applications to enable secure ... With the rise of cloud computing, there has ...
(Date:9/17/2014)... HealthDay Reporter WEDNESDAY, Sept. ... companies have made good on their pledge to cut calories ... companies, acting together through the Healthy Weight Commitment Foundation, pledged ... and 2012 and 1.5 trillion by 2015. They,ve actually reduced ... met their pledge and exceeded their pledge," said lead researcher ...
Breaking Medicine News(10 mins):Health News:Artificial Sweeteners May Raise Blood Sugar Levels: Study 2Health News:Artificial Sweeteners May Raise Blood Sugar Levels: Study 3Health News:Large study reveals new genetic variants that raise risk for prostate cancer 2Health News:Mercy Tops Out World's First Virtual Care Center 2Health News:Celestix Announces Availability of ADFS Bridge Appliance in October 2014 to Simplify the Configuration of Office 365 with Active Directory 2Health News:Major U.S. Food Makers Cut 6.4 Trillion Calories From Products: Report 2Health News:Major U.S. Food Makers Cut 6.4 Trillion Calories From Products: Report 3
... Kiley Carlson of Sioux City, IA will travel ... 31, 2009 to meet with congressional leaders and gain ... research toward a cure for epilepsy.Carlson, 16, is one ... in Kids Speak Up! , a national program ...
... Findings of Pilot Study at East African Health Conference ... Danya International, Inc. (Danya), a communications, research, ... pilot study on the effectiveness of mobile video-enabled phones ... tuberculosis (TB) patients during the 3rd East African Health ...
... Milwaukee MD Saves Patients Money and Improves Health ... To save you money and save your ... may need to be part medical detective as ... http://www.newscom.com/cgi-bin/prnh/20090323/NY86411-a ) , (Photo: http://www.newscom.com/cgi-bin/prnh/20090323/NY86411-b ...
... HOUSTON - Just more than one year after it was ... of Texas M. D. Anderson Cancer Center has introduced a ... generations of women scientists to come. , Legends and ... D. Anderson Cancer Center presents the reflections of 26 current ...
... statutory health insurances in Germany have offered an endoscopic ... all insured persons from the age of 55. Germany ... for bowel cancer a part of its statutory early ... Professor Hermann Brenner at DKFZ have now published a ...
... Scientists at the University of Liverpool have demonstrated how ... be a source of Salmonella transmission to ... living creatures that can contaminate almost any food type, ... that Salmonella which can also cause ...
Cached Medicine News:Health News:Iowa Youth Shares Epilepsy Message on Capitol Hill 2Health News:Pilot Study Using Video Cell Phones for Mobile Direct Observation Treatment (MDOT) to Monitor Medication Compliance of TB Patients 2Health News:Pilot Study Using Video Cell Phones for Mobile Direct Observation Treatment (MDOT) to Monitor Medication Compliance of TB Patients 3Health News:Pilot Study Using Video Cell Phones for Mobile Direct Observation Treatment (MDOT) to Monitor Medication Compliance of TB Patients 4Health News:Saving Money While Protecting Your Health in Tough Economic Times 2Health News:Saving Money While Protecting Your Health in Tough Economic Times 3Health News:New book chronicles the journeys of women physicians and scientists to fighting cancer 2Health News:New book chronicles the journeys of women physicians and scientists to fighting cancer 3Health News:New book chronicles the journeys of women physicians and scientists to fighting cancer 4Health News:Germany: Colonoscopy prevents 15,000 cancer cases 2Health News:Study shows how Salmonella survives in environment 2
Curved delicate 5 mm blades....
... Micro tissue forceps "micro ... soft spring tension light-weight ... round handles, extremely light ... to handle, fatigueless working, ...
Mini blades....
Operating microscope with motorized zoom and variable focus up to 405 mm....
Medicine Products: